Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 904

1.

Health care costs of diarrheal disease and estimates of the cost-effectiveness of rotavirus vaccination in Vietnam.

Fischer TK, Anh DD, Antil L, Cat ND, Kilgore PE, Thiem VD, Rheingans R, Tho le H, Glass RI, Bresee JS.

J Infect Dis. 2005 Nov 15;192(10):1720-6. Epub 2005 Oct 14.

PMID:
16235169
2.

Cost-effectiveness of introducing a rotavirus vaccine in developing countries: the case of Mexico.

Valencia-Mendoza A, Bertozzi SM, Gutierrez JP, Itzler R.

BMC Infect Dis. 2008 Jul 29;8:103. doi: 10.1186/1471-2334-8-103.

3.

Projected cost-effectiveness of rotavirus vaccination for children in Asia.

Podewils LJ, Antil L, Hummelman E, Bresee J, Parashar UD, Rheingans R.

J Infect Dis. 2005 Sep 1;192 Suppl 1:S133-45.

PMID:
16088797
4.

Costs of diarrheal disease and the cost-effectiveness of a rotavirus vaccination program in kyrgyzstan.

Flem ET, Latipov R, Nurmatov ZS, Xue Y, Kasymbekova KT, Rheingans RD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S195-202. doi: 10.1086/605040.

PMID:
19817600
5.

Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries.

Rheingans RD, Antil L, Dreibelbis R, Podewils LJ, Bresee JS, Parashar UD.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S16-27. doi: 10.1086/605026. Review.

PMID:
19817595
6.

Potential cost-effectiveness of vaccination for rotavirus gastroenteritis in eight Latin American and Caribbean countries.

Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T.

Rev Panam Salud Publica. 2007 Apr;21(4):205-16.

PMID:
17612464
7.

Rotavirus disease burden and impact and cost-effectiveness of a rotavirus vaccination program in kenya.

Tate JE, Rheingans RD, O'Reilly CE, Obonyo B, Burton DC, Tornheim JA, Adazu K, Jaron P, Ochieng B, Kerin T, Calhoun L, Hamel M, Laserson K, Breiman RF, Feikin DR, Mintz ED, Widdowson MA.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S76-84. doi: 10.1086/605058.

PMID:
19817618
8.

[Potential cost effectiveness of a rotavirus vaccine in Chile].

Constenla D, O'Ryan M, Navarrete MS, Antil L, Rheingans RD.

Rev Med Chil. 2006 Jun;134(6):679-88. Epub 2006 Aug 14. Spanish.

9.

Cost-effectiveness and potential impact of rotavirus vaccination in the United States.

Widdowson MA, Meltzer MI, Zhang X, Bresee JS, Parashar UD, Glass RI.

Pediatrics. 2007 Apr;119(4):684-97.

PMID:
17403839
10.

Economic analysis for evidence-based policy-making on a national immunization program: a case of rotavirus vaccine in Thailand.

Muangchana C, Riewpaiboon A, Jiamsiri S, Thamapornpilas P, Warinsatian P.

Vaccine. 2012 Apr 16;30(18):2839-47. doi: 10.1016/j.vaccine.2012.02.047. Epub 2012 Mar 2.

PMID:
22387220
11.

Health economics of rotavirus immunization in Vietnam: potentials for favorable cost-effectiveness in developing countries.

Tu HA, Rozenbaum MH, Coyte PC, Li SC, Woerdenbag HJ, Postma MJ.

Vaccine. 2012 Feb 14;30(8):1521-8. doi: 10.1016/j.vaccine.2011.11.052. Epub 2011 Nov 23.

PMID:
22119590
12.

Economic evaluation of a routine rotavirus vaccination programme in Indonesia.

Wilopo SA, Kilgore P, Kosen S, Soenarto Y, Aminah S, Cahyono A, Ulfa M, Tholib A.

Vaccine. 2009 Nov 20;27 Suppl 5:F67-74. doi: 10.1016/j.vaccine.2009.09.040.

PMID:
19931723
13.

Projected health and economic impact of rotavirus vaccination in GAVI-eligible countries: 2011-2030.

Atherly DE, Lewis KD, Tate J, Parashar UD, Rheingans RD.

Vaccine. 2012 Apr 27;30 Suppl 1:A7-14. doi: 10.1016/j.vaccine.2011.12.096.

PMID:
22520139
14.

Economic impact of a rotavirus vaccination program in Mexico.

Constenla D, Velázquez FR, Rheingans RD, Antil L, Cervantes Y.

Rev Panam Salud Publica. 2009 Jun;25(6):481-90.

15.

Cost-effectiveness of childhood rotavirus vaccination in Taiwan.

Wu CL, Yang YC, Huang LM, Chen KT.

Vaccine. 2009 Mar 4;27(10):1492-9. doi: 10.1016/j.vaccine.2009.01.023. Epub 2009 Jan 30.

PMID:
19186200
16.

Potential impact and cost-effectiveness analysis of rotavirus vaccination of children in Israel.

Chodick G, Waisbourd-Zinman O, Shalev V, Kokia E, Rabinovich M, Ashkenazi S.

Eur J Public Health. 2009 Jun;19(3):254-9. doi: 10.1093/eurpub/ckp005. Epub 2009 Feb 12.

PMID:
19221026
17.

Impact of transmission dynamics on the cost-effectiveness of rotavirus vaccination.

Shim E, Galvani AP.

Vaccine. 2009 Jun 19;27(30):4025-30. doi: 10.1016/j.vaccine.2009.04.030. Epub 2009 May 3.

PMID:
19389452
18.

Cost-benefit analysis of a rotavirus immunization program in the Arab Republic of Egypt.

Ortega O, El-Sayed N, Sanders JW, Abd-Rabou Z, Antil L, Bresee J, Mansour A, Adib I, Nahkla I, Riddle MS.

J Infect Dis. 2009 Nov 1;200 Suppl 1:S92-8. doi: 10.1086/605057.

PMID:
19817621
19.

Cost-effectiveness analysis of vaccination against rotavirus with RIX4414 in France.

Standaert B, Parez N, Tehard B, Colin X, Detournay B.

Appl Health Econ Health Policy. 2008;6(4):199-216. doi: 10.2165/00148365-200806040-00003.

PMID:
19382820
20.

Economic and health burden of rotavirus gastroenteritis for the 2003 birth cohort in eight Latin American and Caribbean countries.

Rheingans RD, Constenla D, Antil L, Innis BL, Breuer T.

Rev Panam Salud Publica. 2007 Apr;21(4):192-204.

PMID:
17612463

Supplemental Content

Support Center